• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALT
Click for more information
0.00% 0.5¢

ANALYTICA LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Analytica Limited is engaged in the design, development and supply of Class I and II... Analytica Limited is engaged in the design, development and supply of Class I and II medical devices. The Company's segments include Medical devices and Corporate. The Medical devices segment's products include PeriCoach (Perineometer), ELF-2 and AutoStart burette. The Company's lead product is the PeriCoach System, an e-health treatment system for women suffering from stress urinary incontinence. PeriCoach includes a device, Web portal and smartphone application. The device evaluates activity in pelvic floor muscles. The information is transmitted to a smartphone application and can be loaded to PeriCloud where physicians can monitor patient progress through Web portal. The Analytica Autostart Infusion System offers solution to regular monitoring and refilling of burettes in intravenous fluid infusion. The Autostart burette contains a float system that automatically restarts intra-venous (IV) fluid flow following infused delivery of the predetermined amount of a required medication.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
ALT Receipt of R and D cash refund28/03/19
ALT Appendix 4D and Half Year AccountsPRICE SENSITIVE27/02/19
ALT Expiry of unlisted options13/02/19
ALT Appendix 4C - quarterlyPRICE SENSITIVE31/01/19
ALT Shareholder Update on US Sales CapabilityPRICE SENSITIVE18/12/18
ALT Results of Meeting22/11/18
ALT CEO presentation to AGMPRICE SENSITIVE22/11/18
ALT Chairman's Address to ShareholdersPRICE SENSITIVE22/11/18
ALT Appendix 4C - quarterlyPRICE SENSITIVE31/10/18
ALT Expiry of unlisted options30/10/18
ALT Notice of Annual General Meeting/Proxy Form19/10/18
ALT Pericoach Manufacturing Update08/10/18
ALT Change in Registered Office03/09/18
ALT Corporate Governance Statement30/08/18
ALT Appendix 4G30/08/18
ALT Appendix 4E and Annual ReportPRICE SENSITIVE30/08/18
ALT PeriCoach Real World Data Analysis Statistically SignificantPRICE SENSITIVE21/08/18
ALT Change of Director's Interest Notice31/07/18
ALT Appendix 4C - quarterlyPRICE SENSITIVE31/07/18
ALT Change in directors interest notice - 315/06/18 download Created with Sketch. 378.86KB
ALT Change in substantial holding15/06/18 download Created with Sketch. 31.32KB
ALT Change in substantial holding15/06/18 download Created with Sketch. 29.57KB
ALT Cleansing Notice13/06/18 download Created with Sketch. 105.82KB
ALT Appendix 3B13/06/18 download Created with Sketch. 418.72KB
ALT Exercise of Unlisted options and placement amendment12/06/18 download Created with Sketch. 103.18KB
ALT Exercise of unlisted options and placementPRICE SENSITIVE12/06/18 download Created with Sketch. 103.17KB
ALT TGA clearnance to assist treatment of Pelvic Organ ProlapsePRICE SENSITIVE02/05/18
ALT Appendix 4C - quarterlyPRICE SENSITIVE30/04/18
ALT Update on Pericoach manufacture for USA market23/03/18
ALT Appendix 4D and Half Year ReportPRICE SENSITIVE28/02/18
ALT Suspension from Official Quotation - ALTOAPRICE SENSITIVE26/02/18
ALT Change in substantial holding M Monsour09/02/18
ALT Change of Director's Interest Notice09/02/18
ALT S 708A notice07/02/18
ALT Option exercise and appendix 3b07/02/18
ALT Analytica Senate Committee SubmissionPRICE SENSITIVE30/01/18
ALT Appendix 4C - quarterlyPRICE SENSITIVE29/01/18
ALT Notice of expiry date for unlisted options - January 31 201827/12/17
ALT Appendix 3B22/12/17
ALT Link Market Services - Change of Brisbane Address18/12/17
ALT Change of Director's Interest Notice x 204/12/17
ALT Appendix 3B04/12/17
ALT Final Director's Interest Notice - Carl Stubbings01/12/17
ALT Final Director's Interest Notice - Warren Brooks01/12/17
ALT Results of Meeting30/11/17
ALT AGM Chairman's Address and CEO Presentation30/11/17
ALT Appointment of Navigant Capital AdvisorsPRICE SENSITIVE06/11/17
ALT Appendix 4C - quarterlyPRICE SENSITIVE31/10/17
ALT Section 708A notice31/10/17
ALT Allotment of rights issue shortfall shares31/10/17
ALT Notice of Annual General Meeting/Proxy Form27/10/17
ALT Change of Director's Interest Notice - 420/10/17
ALT Appendix 3B19/10/17
ALT Successful completion of entitlement offer17/10/17
ALT Appendix 4G and Corporate Governance Statement28/09/17
ALT Annual Report to shareholders28/09/17
ALT Corporate Plan Update27/09/17
ALT Replacement ProspectusPRICE SENSITIVE26/09/17
ALT Rights issue letter to option holders18/09/17
ALT Rights Issue letter to ineligible shareholders18/09/17
ALT Rigths Issue letter to eligible shareholders18/09/17
ALT Rights Issue entitlement offer18/09/17
ALT Appendix 3B18/09/17
ALT Renounceable IssuePRICE SENSITIVE18/09/17
ALT Appendix 4E and financial statementsPRICE SENSITIVE31/08/17
ALT Response to Appendix 4C QueryPRICE SENSITIVE09/08/17
ALT Appendix 4C - quarterlyPRICE SENSITIVE31/07/17
ALT Appendix 3B28/06/17
ALT Options issued under ESOP correction09/06/17
ALT Issue of Options under ESOP09/06/17
ALT Appendix 3x - Dr P Corr24/05/17
ALT Director Appointment - Dr Peter Corr23/05/17
ALT PeriCoach granted patent protection in AustraliaPRICE SENSITIVE11/05/17
ALT PeriCoach structured exercise program releasedPRICE SENSITIVE04/05/17
ALT Release of PeriCoach Version 3PRICE SENSITIVE01/05/17
ALT Appendix 4C - quarterlyPRICE SENSITIVE28/04/17
ALT Updated guidelines for surgical managment of SUI patients26/04/17
ALT Change in substantial holding - Dr Monsour24/04/17
ALT Section 708A Notice24/04/17
ALT Change in substantial holding - Invo8 LLC24/04/17
ALT Change of Director's Interest Notice - Dr Monsour24/04/17
ALT Change of Director's Interest Notice - Ross Mangelsdorf24/04/17
ALT Appendix 3B - issue of shares approved at EGM24/04/17
ALT Results of EGM12/04/17
ALT S708A Notice17/03/17
ALT Appendix 3b17/03/17
ALT Notice of Extraordinary General Meeting/Proxy Form10/03/17
ALT Section 708A Notice09/03/17
ALT Appendix 3B09/03/17
ALT Half Year results summary28/02/17
ALT Appendix 4D andf half year accountsPRICE SENSITIVE28/02/17
ALT Pericoach granted Japanese PatentPRICE SENSITIVE22/02/17
ALT Positive clinical trial results for PericoachPRICE SENSITIVE21/02/17
ALT Change in substantial holding16/02/17
ALT Notice under section 708A16/02/17
ALT Appendix 3B16/02/17
ALT Appendix 4C - quarterlyPRICE SENSITIVE31/01/17
ALT PlacementPRICE SENSITIVE31/01/17
ALT PeriCoach Post Market Survey FIndingsPRICE SENSITIVE13/01/17
ALT Change of Director's Interest Notice - issue of options22/12/16
ALT Receipt of R and D cash refund
28/03/19
ALT Appendix 4D and Half Year Accounts
27/02/19PRICE SENSITIVE
ALT Expiry of unlisted options
13/02/19
ALT Appendix 4C - quarterly
31/01/19PRICE SENSITIVE
ALT Shareholder Update on US Sales Capability
18/12/18PRICE SENSITIVE
ALT Results of Meeting
22/11/18
ALT CEO presentation to AGM
22/11/18PRICE SENSITIVE
ALT Chairman's Address to Shareholders
22/11/18PRICE SENSITIVE
ALT Appendix 4C - quarterly
31/10/18PRICE SENSITIVE
ALT Expiry of unlisted options
30/10/18
ALT Notice of Annual General Meeting/Proxy Form
19/10/18
ALT Pericoach Manufacturing Update
08/10/18
ALT Change in Registered Office
03/09/18
ALT Corporate Governance Statement
30/08/18
ALT Appendix 4G
30/08/18
ALT Appendix 4E and Annual Report
30/08/18PRICE SENSITIVE
ALT PeriCoach Real World Data Analysis Statistically Significant
21/08/18PRICE SENSITIVE
ALT Change of Director's Interest Notice
31/07/18
ALT Appendix 4C - quarterly
31/07/18PRICE SENSITIVE
ALT Change in directors interest notice - 3
15/06/18 download Created with Sketch. 378.86KB
ALT Change in substantial holding
15/06/18 download Created with Sketch. 31.32KB
ALT Change in substantial holding
15/06/18 download Created with Sketch. 29.57KB
ALT Cleansing Notice
13/06/18 download Created with Sketch. 105.82KB
ALT Appendix 3B
13/06/18 download Created with Sketch. 418.72KB
ALT Exercise of Unlisted options and placement amendment
12/06/18 download Created with Sketch. 103.18KB
ALT Exercise of unlisted options and placement
12/06/18PRICE SENSITIVE download Created with Sketch. 103.17KB
ALT TGA clearnance to assist treatment of Pelvic Organ Prolapse
02/05/18PRICE SENSITIVE
ALT Appendix 4C - quarterly
30/04/18PRICE SENSITIVE
ALT Update on Pericoach manufacture for USA market
23/03/18
ALT Appendix 4D and Half Year Report
28/02/18PRICE SENSITIVE
ALT Suspension from Official Quotation - ALTOA
26/02/18PRICE SENSITIVE
ALT Change in substantial holding M Monsour
09/02/18
ALT Change of Director's Interest Notice
09/02/18
ALT S 708A notice
07/02/18
ALT Option exercise and appendix 3b
07/02/18
ALT Analytica Senate Committee Submission
30/01/18PRICE SENSITIVE
ALT Appendix 4C - quarterly
29/01/18PRICE SENSITIVE
ALT Notice of expiry date for unlisted options - January 31 2018
27/12/17
ALT Appendix 3B
22/12/17
ALT Link Market Services - Change of Brisbane Address
18/12/17
ALT Change of Director's Interest Notice x 2
04/12/17
ALT Appendix 3B
04/12/17
ALT Final Director's Interest Notice - Carl Stubbings
01/12/17
ALT Final Director's Interest Notice - Warren Brooks
01/12/17
ALT Results of Meeting
30/11/17
ALT AGM Chairman's Address and CEO Presentation
30/11/17
ALT Appointment of Navigant Capital Advisors
06/11/17PRICE SENSITIVE
ALT Appendix 4C - quarterly
31/10/17PRICE SENSITIVE
ALT Section 708A notice
31/10/17
ALT Allotment of rights issue shortfall shares
31/10/17
ALT Notice of Annual General Meeting/Proxy Form
27/10/17
ALT Change of Director's Interest Notice - 4
20/10/17
ALT Appendix 3B
19/10/17
ALT Successful completion of entitlement offer
17/10/17
ALT Appendix 4G and Corporate Governance Statement
28/09/17
ALT Annual Report to shareholders
28/09/17
ALT Corporate Plan Update
27/09/17
ALT Replacement Prospectus
26/09/17PRICE SENSITIVE
ALT Rights issue letter to option holders
18/09/17
ALT Rights Issue letter to ineligible shareholders
18/09/17
ALT Rigths Issue letter to eligible shareholders
18/09/17
ALT Rights Issue entitlement offer
18/09/17
ALT Appendix 3B
18/09/17
ALT Renounceable Issue
18/09/17PRICE SENSITIVE
ALT Appendix 4E and financial statements
31/08/17PRICE SENSITIVE
ALT Response to Appendix 4C Query
09/08/17PRICE SENSITIVE
ALT Appendix 4C - quarterly
31/07/17PRICE SENSITIVE
ALT Appendix 3B
28/06/17
ALT Options issued under ESOP correction
09/06/17
ALT Issue of Options under ESOP
09/06/17
ALT Appendix 3x - Dr P Corr
24/05/17
ALT Director Appointment - Dr Peter Corr
23/05/17
ALT PeriCoach granted patent protection in Australia
11/05/17PRICE SENSITIVE
ALT PeriCoach structured exercise program released
04/05/17PRICE SENSITIVE
ALT Release of PeriCoach Version 3
01/05/17PRICE SENSITIVE
ALT Appendix 4C - quarterly
28/04/17PRICE SENSITIVE
ALT Updated guidelines for surgical managment of SUI patients
26/04/17
ALT Change in substantial holding - Dr Monsour
24/04/17
ALT Section 708A Notice
24/04/17
ALT Change in substantial holding - Invo8 LLC
24/04/17
ALT Change of Director's Interest Notice - Dr Monsour
24/04/17
ALT Change of Director's Interest Notice - Ross Mangelsdorf
24/04/17
ALT Appendix 3B - issue of shares approved at EGM
24/04/17
ALT Results of EGM
12/04/17
ALT S708A Notice
17/03/17
ALT Appendix 3b
17/03/17
ALT Notice of Extraordinary General Meeting/Proxy Form
10/03/17
ALT Section 708A Notice
09/03/17
ALT Appendix 3B
09/03/17
ALT Half Year results summary
28/02/17
ALT Appendix 4D andf half year accounts
28/02/17PRICE SENSITIVE
ALT Pericoach granted Japanese Patent
22/02/17PRICE SENSITIVE
ALT Positive clinical trial results for Pericoach
21/02/17PRICE SENSITIVE
ALT Change in substantial holding
16/02/17
ALT Notice under section 708A
16/02/17
ALT Appendix 3B
16/02/17
ALT Appendix 4C - quarterly
31/01/17PRICE SENSITIVE
ALT Placement
31/01/17PRICE SENSITIVE
ALT PeriCoach Post Market Survey FIndings
13/01/17PRICE SENSITIVE
ALT Change of Director's Interest Notice - issue of options
22/12/16
refresh Created with Sketch. REFRESH
 

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Tambourah chases gold veins and mineralisation extension with drilling Tambourah Metals Ltd has discovered two high-grade gold veins through a diamond drilling program in Western Australia
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.